CPG
CYTK icon

Cornerstone Planning Group’s Cytokinetics CYTK Stock Holding History

Cornerstone Planning Group’s Portfolio CYTK Stock Details CYTK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$658 Buy
+8
New +$574 ﹤0.01% 1612
2025
Q2 		– Sell
-8
Closed -$304 – 1565
2025
Q1 		$304 Buy
+8
New +$368 ﹤0.01% 1408

Other funds holding CYTK

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Cornerstone Planning Group's CYTK Position: Q2 2026 in Review

Cornerstone Planning Group opened a new position in Cytokinetics (CYTK) in Q2 2026: 8 shares worth $658. The stake represents ﹤0.01% of the portfolio and ranks #1612 among its holdings. This is a return to the name: Cornerstone Planning Group previously reported a position in CYTK as recently as Q1 2025.

Cornerstone Planning Group first reported a position in CYTK in Q1 2025 and has held it in 2 quarters since. 484 funds tracked by Wall St. Rank hold CYTK as of Q2 2026.

  • Cornerstone Planning Group held 8 shares of Cytokinetics worth $658 as of Q2 2026.
  • Cytokinetics was a new Cornerstone Planning Group position in Q2 2026.
  • Cytokinetics made up ﹤0.01% of Cornerstone Planning Group's portfolio in Q2 2026, its #1612 holding.
  • Cornerstone Planning Group first reported a position in Cytokinetics in Q1 2025 and has held it in 2 quarters since.
  • 484 funds tracked by Wall St. Rank held Cytokinetics as of Q2 2026.

Based on Cornerstone Planning Group's 13F filing for Q2 2026, filed 29 Jul 2026.